On February 4, a Letter to the Editor was published online in Science and Engineering Ethics (read HERE), addressing some of China’s current problems related to biomedical research. In the article, the authors refer to the fact that Jian-kui He, a professor at the Southern University of Science and Technology in China, had recently announced that he had managed to produce the first babies genetically modified to make them immune to HIV, using CRISPR Cas9, and that he had presented his work at the Second International Summit on Human Genome Editing in Hong Kong. His announcement caused a huge shock and even greater controversy among the scientific community.
Similarly in November 2017, Xiao-ping Ren and his group from Harbin Medical University, also in China, announced that they had carried out the first head-to-body transplant on a corpse.
